All Stories

  1. The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma
  2. Complete response under sorafenib in patients with hepatocellular carcinoma. Relationship with dermatologic adverse events
  3. Características clínicas del carcinoma hepatocelular en España. Comparación con el período 2008-2009 y análisis de las causas del diagnóstico fuera de cribado. Estudio de 686 casos en 73 centros
  4. Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
  5. Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients
  6. Unique Genomic Profile of Fibrolamellar Hepatocellular Carcinoma
  7. Phylogenetic Demonstration of Hepatitis E Infection Transmitted by Pork Meat Ingestion
  8. Prognostic Gene Expression Signature for Patients With Hepatitis C–Related Early-Stage Cirrhosis
  9. Single HCC in Cirrhotic Patients: Liver Resection or Liver Transplantation? Long-term Outcome According to an Intention-to-treat Basis
  10. Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
  11. Reply to: “Network-based discovery of gene signature for vascular invasion prediction in HCC”
  12. Combination therapy for hepatocellular carcinoma: Additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib
  13. Abstract 4718: Potent preclinical antitumor effects induced by pan-histone deacetylase inhibitor panobinostat in combination with sorafenib in hepatocellular carcinoma
  14. Gene-expression signature of vascular invasion in hepatocellular carcinoma
  15. MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a
  16. Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study
  17. Diagnostic and Prognostic Molecular Markers in Hepatocellular Carcinoma
  18. Abstract 2996: Overexpression of potential oncogenic microRNAs defines a new molecular subclass of hepatocellular carcinoma
  19. Abstract LB-233: IGF activation in a molecular subclass of hepatocellular carcinoma and preclinical efficacy of IGF-1R blockage
  20. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage
  21. Molecular Classification and Novel Targets in Hepatocellular Carcinoma: Recent Advancements
  22. Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
  23. Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo
  24. Pathogenesis of hepatocellular carcinoma and molecular therapies
  25. Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
  26. Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma
  27. Hepatic Encephalopathy
  28. La firma genética para el diagnóstico molecular del carcinoma hepatocelular
  29. Decreased white matter lesion volume and improved cognitive function after liver transplantation
  30. Decrease in the Volume of White Matter Lesions with Improvement of Hepatic Encephalopathy
  31. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy
  32. Treatment of hepatic encephalopathy
  33. Síndrome febril por infección por el virus de Epstein-Barr en la enfermedad de Crohn